Reform of the EU pharmaceutical legislation: challenges and opportunities

The new EU Pharmaceutical Legislation is set to influence the future of research, development, and manufacturing in Europe for years to come. This evolving regulatory landscape brings new rules, new challenges, and plenty of opportunities. As we face these forthcoming changes, we brought together perspectives from leading voices in academia, public institutions and the pharmaceutical industry to explore the following topics:

• New framework for regulatory data protection and market exclusivity
• Tackling medicinal product shortages and ensuring supply security
• The European Health Data Space
• New developments in medicinal product advertising